Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 82804-038

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 82804-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Venlafaxine Fig1)

Figure (Venlafaxine Fig1)
A scatter plot chart showing fold change and 90% confidence interval for pharmacokinetic parameters (Cmax and AUC) of venlafaxine in various special populations, including hepatic (cirrhosis, mild and moderate impairment), renal (mild/moderate impairment, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender. The x-axis represents change relative to the reference value.*
FDA Label Image

Figure (Venlafaxine Fig2)

Figure (Venlafaxine Fig2)
A scientific chart depicting the fold change and 90% confidence interval of venlafaxine analyte pharmacokinetic parameters (Cmax and AUC) in the presence of various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 extensive and poor metabolizers), indinavir, metoprolol, imipramine, and lithium. The x-axis shows change relative to the reference value, illustrating how each interacting drug affects venlafaxine exposure.*
FDA Label Image

Figure (Venlafaxine Fig3)

Figure (Venlafaxine Fig3)
A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various interacting drugs and their analytes relative to a reference value. Drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*
FDA Label Image

82804-038-30 (Venlafaxine Fig8)

82804-038-30 (Venlafaxine Fig8)
Label for Venlafaxine HCl 150 mg extended-release capsules by Proficient Rx LP. The label indicates a 30 count package with the active ingredient venlafaxine hydrochloride USP equivalent to 150 mg venlafaxine per capsule. Capsules are described as white to off-white spherical to oval pellets in dark orange hard gelatin capsule shells imprinted with 'E' on the cap and '89' on the body. Manufactured by Aurobindo Pharma Limited, Hyderabad, India.*
FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical Structure (Venlafaxine Str)
Chemical structure of venlafaxine hydrochloride, showing its molecular composition with characteristic rings and functional groups labeled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.